These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1976 related articles for article (PubMed ID: 8228328)

  • 1. Novel and known protein tyrosine kinases and their abnormal expression in human melanoma.
    Easty DJ; Ganz SE; Farr CJ; Lai C; Herlyn M; Bennett DC
    J Invest Dermatol; 1993 Nov; 101(5):679-84. PubMed ID: 8228328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis.
    Easty DJ; Herlyn M; Bennett DC
    Int J Cancer; 1995 Jan; 60(1):129-36. PubMed ID: 7814145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes.
    Lee ST; Strunk KM; Spritz RA
    Oncogene; 1993 Dec; 8(12):3403-10. PubMed ID: 8247543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein tyrosine phosphatase genes downregulated in melanoma.
    McArdle L; Rafferty M; Maelandsmo GM; Bergin O; Farr CJ; Dervan PA; O'Loughlin S; Herlyn M; Easty DJ
    J Invest Dermatol; 2001 Nov; 117(5):1255-60. PubMed ID: 11710941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of a cDNA encoding a tyrosine kinase expressed in murine skin.
    Kawachi Y; Nakauchi H; Otsuka F
    Exp Dermatol; 1997 Jun; 6(3):140-6. PubMed ID: 9226137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinases in normal and transformed melanocytes.
    Quong RY; Bickford ST; Ing YL; Terman B; Herlyn M; Lassam NJ
    Melanoma Res; 1994 Oct; 4(5):313-9. PubMed ID: 7858416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas.
    Funasaka Y; Boulton T; Cobb M; Yarden Y; Fan B; Lyman SD; Williams DE; Anderson DM; Zakut R; Mishima Y
    Mol Biol Cell; 1992 Feb; 3(2):197-209. PubMed ID: 1372524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein tyrosine kinases in malignant melanoma.
    Easty DJ; Bennett DC
    Melanoma Res; 2000 Oct; 10(5):401-11. PubMed ID: 11095400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: a result of transformation or differentiation?
    Gilhooly EM; Morse-Gaudio M; Bianchi L; Reinhart L; Rose DP; Connolly JM; Reed JA; Albino AP
    Melanoma Res; 2001 Aug; 11(4):355-69. PubMed ID: 11479424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
    Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
    Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of expression of receptor tyrosine kinase family genes PTK7 and SEK in metastatic melanoma.
    Easty DJ; Mitchell PJ; Patel K; Flørenes VA; Spritz RA; Bennett DC
    Int J Cancer; 1997 Jun; 71(6):1061-5. PubMed ID: 9185712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intertumoral heterogeneity of receptor-tyrosine kinases expression in human melanoma cell lines with different metastatic capabilities.
    Gutman M; Singh RK; Radinsky R; Bar-Eli M
    Anticancer Res; 1994; 14(5A):1759-65. PubMed ID: 7847808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTK1, a novel protein kinase required for proliferation of human melanocytes.
    Ezoe K; Lee ST; Strunk KM; Spritz RA
    Oncogene; 1994 Mar; 9(3):935-8. PubMed ID: 8108137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of protein kinase C and cAMP-dependent protein kinase in normal human melanocytes and malignant melanomas.
    Becker D; Beebe SJ; Herlyn M
    Oncogene; 1990 Aug; 5(8):1133-9. PubMed ID: 2392322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth factors and tyrosine protein kinases in normal and malignant melanocytes.
    Halaban R
    Cancer Metastasis Rev; 1991 Jun; 10(2):129-40. PubMed ID: 1873853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated procaspase levels in human melanoma.
    Fink D; Schlagbauer-Wadl H; Selzer E; Lucas T; Wolff K; Pehamberger H; Eichler HG; Jansen B
    Melanoma Res; 2001 Aug; 11(4):385-93. PubMed ID: 11479427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Putative tyrosine kinases expressed in K-562 human leukemia cells.
    Partanen J; Mäkelä TP; Alitalo R; Lehväslaiho H; Alitalo K
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8913-7. PubMed ID: 2247464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor tyrosine kinases and their activation in melanoma.
    Easty DJ; Gray SG; O'Byrne KJ; O'Donnell D; Bennett DC
    Pigment Cell Melanoma Res; 2011 Jun; 24(3):446-61. PubMed ID: 21320293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression.
    Easty DJ; Guthrie BA; Maung K; Farr CJ; Lindberg RA; Toso RJ; Herlyn M; Bennett DC
    Cancer Res; 1995 Jun; 55(12):2528-32. PubMed ID: 7780963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression analysis after receptor tyrosine kinase activation reveals new potential melanoma proteins.
    Teutschbein J; Haydn JM; Samans B; Krause M; Eilers M; Schartl M; Meierjohann S
    BMC Cancer; 2010 Jul; 10():386. PubMed ID: 20663135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 99.